Supplementary Data from Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib

MLA

Nicholas Mitsiades, et al. Supplementary Data from Interactions of the Hdm2/P53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22439989.

APA

Nicholas Mitsiades, Kenneth C. Anderson, Constantine S. Mitsiades, Paul G. Richardson, Peter O’Gorman, Martin Clynes, Leutz Buon, Teru Hideshima, Dharminder Chauhan, Nikhil C. Munshi, Noopur S. Raje, Emily Daskalaki, Elpida Charalambous, Douglas W. McMillin, Vassiliki Kotoula, Patrick J. Hayden, & Melissa G. Ooi. (2023). Supplementary Data from Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib. https://doi.org/10.1158/1078-0432.22439989

Chicago

Nicholas Mitsiades, Kenneth C. Anderson, Constantine S. Mitsiades, Paul G. Richardson, Peter O’Gorman, Martin Clynes, Leutz Buon, et al. 2023. “Supplementary Data from Interactions of the Hdm2/P53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib,” March. doi:10.1158/1078-0432.22439989.